Holoprosencephaly (HPE) is a major structural birth defect of the brain that occurs in approximately 1 in 10,000 live births. Although some genetic causes of HPE are known, a substantial proportion of cases have an unknown etiology. Due to the low birth prevalence and rarity of exposure to many potential risk factors for HPE, few epidemiologic studies have had sufficient sample size to examine risk factors. A 2010 review of the literature identified several risk factors that had been consistently identified as occurring more frequently among cases of HPE, including maternal diabetes, twinning, and a predominance of females, while also identifying a number of potential risk factors that had been less widely studied. In this article, we summarize a systematic literature review conducted to update the evidence for nongenetic risk factors for HPE.
registries, can provide opportunities to evaluate risk factors for HPE in humans over time and with appropriate comparison groups. However, given the low birth prevalence of HPE and rarity of many exposures of interest, such as medication use or infections during pregnancy, few epidemiologic studies have adequate sample size, and statistical power to evaluate many potential risk factors. These epidemiologic studies are typically retrospective case-control studies that investigate a spectrum of risk factors for HPE or are studies of specific risk factors that have included HPE as one of many defects studied.
A 2010 review identified four large case-control studies that focused on risk factors for HPE and a few other studies that examined factors associated with a range of birth defects including HPE (Johnson & Rasmussen, 2010) . The most extensively studied risk factor identified by the review was maternal diabetes, with numerous studies observing a prevalence of pre-existing and gestational diabetes at least twice as high among mothers of children with HPE as mothers of controls (Anderson et al., 2005; Correa et al., 2008; Croen, Shaw, & Lammer, 2000; Martínez-Frías, Bermejo, Rodríguez-Pinilla, Prieto, & Frías, 1998; Orioli & Castilla, 2007) . Sex ratio has also been widely studied, with many studies finding an excess of females with HPE (Croen et al., 2000; Kallen et al., 1992; Olsen, Hughes, Youngblood, & SharpeStimac, 1997; Orioli & Castilla, 2007; Rasmussen et al., 1996; Whiteford & Tolmie, 1996) . HPE has also consistently been observed to occur more frequently among twins or other multiple births than singletons (Bullen, Rankin, & Robson, 2001; Miller, Rasmussen, Siega-Riz, Frias, & Honein, 2010; Odent, Le Marec, Munnich, Le Merrer, & Bonaïti-Pelli e, 1998) .
According to the 2010 review, a number of other maternal demographic characteristics and exposures have been identified as potential risk factors for HPE, but there was less evidence to support these.
Epidemiologic studies assessing the use of aspirin and salicylates have had inconsistent results, with two studies finding an association with HPE and one that did not (Croen et al., 2000; Miller et al., 2010; Orioli & Castilla, 2007) . Other factors such as use of assisted reproductive technologies and maternal sexually transmitted infections may increase the risk of HPE and warrant future study (Croen et al., 2000; Miller et al., 2010 ).
In the current manuscript, we update the evidence for nongenetic risk factors for HPE based on a systematic review of the literature published since the 2010 review was conducted (Johnson & Rasmussen, 2010) . Given the limited conclusions that can be drawn from case reports and animal studies, we have elected to restrict this review to epidemiologic studies.
| M E TH ODS
Because studies in which HPE was included as one of many defects under investigation for a particular risk factor might be missed in a traditional systematic literature review, we conducted our review in multiple phases ( Figure 1 ). We first searched for "holoprosencephaly" using Medline (OVID), Embase (OVID), CINAHL (Ebsco), and Scopus databases (see Appendix A for full search strategy). We supplemented this with a search of full texts in an internal library of publications from the National Birth Defects Prevention Study (NBDPS), a case-control study that included rare defects such as HPE. We included publications from January 2009 through January 2018. After this first phase identified 57 epidemiologic studies and case reports that were potentially of interest, we searched for "holoprosencephaly" among the full text of the publications citing and cited by these publications. We limited the publications included in this review to those with at least five cases of HPE that were not included in the 2010 review paper. The full texts of these publications were reviewed and 17 publications were included in this review.
| RE S U L TS

| National Birth Defects Prevention Study
Between 2009 and January 2018, 14 publications using data from the NBDPS included HPE as an outcome of interest (Table 1) ; however, one previous study of nongenetic risk factors for HPE published during this time period was included in the 2010 review and excluded from the current review (Miller et al., 2010) . The NBDPS was a population-based case-control study of major birth defects that was conducted for births in 10 U.S. states between October 1997 and December 2011. NBDPS methods for recruitment of participants and case classification have been described in detail elsewhere (Rasmussen et al., 2003; Reefhuis et al., 2015; Yoon et al., 2001) . Briefly, NBDPS cases include infants or fetuses with one or more major structural birth defect identified through population-based active case-finding surveillance systems in Arkansas, California, Georgia, Iowa, Massachusetts, New Jersey, New York, North Carolina, Texas, and Utah. Cases were reviewed by a clinical geneticist, classified as isolated or multiple (>1 major unrelated birth defect in separate organ systems), and those with single-gene disorders or recognized chromosomal syndromes were excluded (Rasmussen et al., 2003) . For inclusion, diagnoses of HPE in cases needed to be confirmed postnatally, either by imaging studies or post-mortem examination. Liveborn infants without major birth defects (controls) were randomly selected from the same ascertainment areas as cases using birth certificates or hospital birth records.
Mothers of cases and controls participated in a computer-assisted telephone interview, conducted in English or Spanish, between six weeks and 24 months after their expected date of delivery. The interview included detailed questions concerning pregnancy history, demographic information, and exposures, such as medication use and maternal infections, during the time period of three months before conception through the end of pregnancy. During the entire study period, the interview participation rate was approximately 65% for mothers of controls (n 5 11,814) and 67% for mothers of children with HPE (n 5 32,187) (Reefhuis et al., 2015) . Between 1997 and 2011, 321 cases of HPE were ascertained and 181 mothers were interviewed; this includes cases of isolated HPE and cases with HPE and other major birth defects (multiple). Because analyses of NBDPS data were conducted throughout the study period and the inclusion criteria for each analysis varied, the number of cases and controls included varied.
Unless otherwise noted, all NBDPS analyses described in this review included both cases of isolated and multiple HPE and exposures occurred during the periconceptional period, from one month prior to conception through the third month of pregnancy.
Of the 13 NBDPS studies included in this review, the first NBDPS analysis we describe included 1997-2003 data, was restricted to mothers without pre-existing diabetes, and found no significant association between periconceptional antibiotic use and HPE (Crider et al., 2009) .
In an analysis of 1997-2004 data, mothers of children with isolated HPE were more than three times more likely than mothers of controls to report a history of thyroid disease, although this finding was based on three exposed cases and was not statistically significant (Browne et al., 2009) . A publication using data from 1997 to 2004 found that mothers of children with HPE were more likely than mothers of controls to have reported a genital tract infection during the first trimester, although this finding was based on two exposed cases and was not statistically significant (Carter et al., 2011) . Among women who took a folic acid-containing multivitamin, maternal diabetes was associated with a ninefold increased risk of HPE (adjusted odds ratio (aOR) 9.06; 95% confidence interval (CI): 1.97-41.77); however, this finding was based on two exposed cases (Correa et al., 2012) . Tinker and colleagues found that mothers of infants with HPE were more than twice as likely to report an injury than mothers of controls, although Model adjusted for maternal age, race, education, prepregnancy body mass index, time from the estimated date of delivery to the interview, use of folic acid or multivitamins containing folic acid from 1 month before pregnancy through the first month of pregnancy, and any periconceptional smoking or alcohol use. b Model adjusted for maternal age, race/ethnicity, education, parity, prepregnancy obesity, family history of a similar birth defect in a first-degree relative, use of folic acid supplements, smoking, alcohol use, and study center. c Models adjusted for maternal age, race, and ethnicity, entry into prenatal care, prepregnancy body mass index, parity, and household income. d Model adjusted for age, race and ethnicity, educational attainment, household income, alcohol use during pregnancy, smoking during pregnancy, prepregnancy body mass index, occupational status, and study site. e Models adjusted for race/ethnicity, body mass index, folic acid use, gravidity, education, smoking, and parental age difference; mothers with missing covariate data are excluded from these analyses.
f Model adjusted for site, maternal age, maternal education, maternal race, and folic acid use in the month prior to or after conception. g Model adjusted for maternal age at delivery (continuous), race, parity, obesity, education, smoking, use of a folic acid-containing multivitamins, and study site. h Model adjusted for maternal age, race, education, and body mass index. i Model adjusted for maternal age, education, race, body mass index, nativity, alcohol intake one month prior to conception through the first trimester, folic acid intake in multivitamins or alone one month prior to conception through the first month of pregnancy, dietary folate equivalent, previous live births, pregnancy intention, household income divided by no. of people supported by this income, study center, and time to interview. j Model adjusted for maternal age, maternal race/ethnicity, and state of residence at the time of birth.
this finding was also not statistically significant (Tinker, Reefhuis, Dellinger, & Jamieson, 2011 Gill et al. (2012) found no association between HPE and maternal age. In a 2012 publication examining the association between birth defects and consumption of foods with a high glycemic index, among women without diabetes, an increased odds ratio was observed for HPE but was not statistically significant (Parker et al., 2012) . In a 2016 publication, Dawson et al. (2016) found a nearly threefold increase in HPE prevalence among members of twins, compared to singletons (aOR 2.7; 95% CI: 1.2-5.8),
which remained elevated in analyses restricted to women who did not use fertility treatments. In a study of data from the Utah NBDPS site, one mother of a child with HPE self-reported cigarette smoking at any time during pregnancy, which was not statistically different from mothers of control infants (Srisukhumbowornchai, Krikov, & Feldkamp, 2012) .
Three later NBDPS analyses included data from 1997 to 2009 (Howley et al., 2016; Hoyt et al., 2016; Michalski et al., 2015) , and one used data from the entire study period of 1997-2011 (Howley et al., 2017) . In a 2015 study of male/female sex ratios, a significant predominance of females was found among the cases with HPE compared to controls (0.62; 95% CI: 0.44-0.87) (Michalski et al., 2015) . This finding remained significant in a sub-analysis restricted to isolated cases. In an analysis examining the association between maternal autoimmune disease and birth defects (excluding mothers with pregestational diabetes), one exposed case of HPE was reported among 134 total cases, a slightly lower proportion of exposure than in the controls (Howley et al., 2016) . In a study of maternal periconceptional secondhand tobacco smoke exposure in the home, workplace or school, exposure was slightly less common among mothers of children with HPE than controls, after excluding cases and controls from multiple births and mothers reporting active smoking or pregestational diabetes (Hoyt et al., 2016) . Lastly, in a 2017 publication, use of thyroid hormones was significantly higher among mothers of children with HPE than among mothers of controls (aOR 2.48; 95% CI 1.13-5.44), based on seven exposed cases; the analysis remained statistically significant when restricted to isolated cases of HPE (Howley et al., 2017) .
| Other epidemiologic studies of HPE
One of the largest studies of HPE to date compared cases with isolated cyclopia to cases with associated malformations and those with chromosomal syndromes (Table 2 ) (Orioli et al., 2011 Of the isolated cases, 60.8% were female, a higher percentage than among cases with other malformations (53.1%) or those with chromosomal syndromes (51.9%), although these differences were not statistically significant. The authors also observed a higher birth prevalence of cyclopia among older mothers, but this was not statistically significant.
Other characteristics such as parity, history of spontaneous abortion, plurality, and parental age difference were not significantly different for multiple birth defects and a strongly suspected structural central nervous system anomaly, they were excluded and the next eligible person was selected as the control. In total, 47 patients with HPE were identified and 47 matched controls were selected; 24 of the cases with HPE were determined to be part of a syndrome. The final analysis included 23 cases of nonsyndromic HPE and all 47 controls. Significant positive associations with HPE were observed for having an Aboriginal parent, either mother or father, and having a family history of a midline facial defect. While the authors reported that mothers of children with HPE were nearly seven times more likely than mothers of controls to report pre-existing diabetes, the study only included three exposed cases and one exposed control and the finding did not reach statistical significance. Other factors that were observed to have elevated odds ratios were based on small numbers and were not statistically significant; these included low socioeconomic status and having had a previous stillbirth or a previous neonatal death. Miller, 2015) . Multivitamin supplements might attenuate the risk for some diabetes-associated birth defects (Correa, Botto, Liu, Mulinare, & Erickson, 2003; Correa et al., 2012) ; however, diabetes was a strong risk factor for HPE, even among women who were taking folic acid containing supplements (Correa et al., 2012) . A better understanding of these mechanisms could lead to future measures to prevent birth defects among women with diabetes.
Twinning has also been associated with several different types of birth defects (Weber & Sebire, 2010) , including HPE. It has been hypothesized that early structural defects (such as HPE) in monozygotic twins might represent cleavage disorders of the midline field (Opitz & Gilbert, 1982; Suslak, Mimms, Desposito, Opitz, & Reynolds, 1987) .
The reason for the female predominance among HPE cases is unclear. Female embryos might be more susceptible to perturbations that cause HPE or male embryos might be more likely to be lost through spontaneous abortion. A large proportion of embryos with HPE are lost prenatally (Matsunaga & Shiota, 1977) ; however, an equal sex ratio among fetuses identified prenatally at 16-36 weeks' gestation (Berry, Gosden, Snijders, & Nicolaides, 1990) suggests that losses at this later stage in pregnancy do not occur more frequently among males.
The association between thyroid hormone use and HPE observed in data from the NBDPS needs to be replicated in other studies.
Whether the observed association is related to use of thyroid hormone, or to the underlying condition for which thyroid hormone treatment is used, or is due to chance is unknown. However, thyroid hormone is necessary for development of the fetal nervous system (Schroeder & Privalsky, 2014) , so the association could be biologically plausible. HPE is a rare and serious birth defect that often results in pregnancy loss, which makes it challenging to identify nongenetic risk factors. Studies with a small number of exposed cases result in unstable effect estimates and wide confidence intervals, making it difficult to distinguish true risk factors from findings observed by chance. To better understand risk factors for HPE, data sets with large numbers of cases and sufficient statistical power are needed. Because HPE has a wide spectrum of phenotypes and is often associated with a chromosomal abnormality or single gene disorder, careful clinical review and classification are also essential to create well-defined outcome categories. In addition, incorporation of information on genetic factors is important to permit the study of gene-environment interaction.
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